Embodiments of a composition and/or combination comprising an anionic dietary supplement and 25-hydroxy vitamin D are disclosed. The anionic dietary supplement may be a negative dietary cation anion difference (DCAD) supplement and/or may comprise magnesium chloride, magnesium sulfate, ammonium chloride, ammonium sulfate, and calcium sulfate, and/or complexes thereof. Also disclosed are embodiments of a method for administrating the combination and/or composition to an animal, such as a ruminant. In certain embodiments, the animal is a dairy cow, and the method may be a method for increasing milk yield, and/or improving the health of the animal.

The present invention relates to dissolvable containers for animal feed micro-ingredients, and methods for using such dissolvable containers to prepare an animal feed mixture. Ingredients required in very small amounts with respect to the rest of the components in an animal feed, i.e., micro-ingredients, can be pre-measured and sealed within the dissolvable containers, which can be made from a water-soluble polymer film, then added to the other feed components when the complete animal feed is being prepared.

A prophylactic and/or therapeutic food composition for control of deformed wing vims (DWV) in bees and/or bee larvae, and methods of using and making the same. Bee feed compositions comprising anti-DWV antibodies dispersed in an edible base composition. Use of recombinant VP1, VP2, VP3, and/or VP4 capsid proteins, or VLPs of deformed wing vims (DWV) to passively generate anti-DWV antibodies in chicken egg yolks, and use of such anti-DWV antibodies for prophylaxis or treatment of deformed wing virus in the bees and/or larvae.

A prophylactic and/or therapeutic food composition for control of deformed wing vims (DWV) in bees and/or bee larvae, and methods of using and making the same. Bee feed compositions comprising anti-DWV antibodies dispersed in an edible base composition. Use of recombinant VP1, VP2, VP3, and/or VP4 capsid proteins, or VLPs of deformed wing vims (DWV) to passively generate anti-DWV antibodies in chicken egg yolks, and use of such anti-DWV antibodies for prophylaxis or treatment of deformed wing virus in the bees and/or larvae.

The present invention relates to compositions comprising 1,2,4-trioxane compounds and chlorogenic acids. The invention further provides a method for the stabilization of 1,2,4-trioxane compounds against degradation, in particular against thermal degradation or degradation induced by reducing agents such as reducing carbohydrates, reducing sugars, electromagnetic radiation or heavy metal ions.

The present invention relates to compositions comprising 1,2,4-trioxane compounds and chlorogenic acids. The invention further provides a method for the stabilization of 1,2,4-trioxane compounds against degradation, in particular against thermal degradation or degradation induced by reducing agents such as reducing carbohydrates, reducing sugars, electromagnetic radiation or heavy metal ions.

This document provides dietary supplement compositions. For example, multi-supplement compositions having combinations of dietary supplement formulations useful for human or animal consumption are provided.

This document provides dietary supplement compositions. For example, multi-supplement compositions having combinations of dietary supplement formulations useful for human or animal consumption are provided.

Disclosed herein are consumable products for pets such as dogs, cats, horses, and birds the consumable products containing a cannabinoid. The consumable products disclosed herein can be formulated as chews or liquid supplements with pleasing flavors in order to encourage the pets to eat the consumable products and derive therapeutic benefits from consumption. The consumable products contain live, active cultures of probiotic microorganisms or may contain spores of probiotic microorganisms. The consumable products have anti-inflammatory effects due to the presence of the cannabinoid but are non-narcotic. Further, the consumable products serve to enhance gut health due to the presence of probiotics. The consumable products are particularly useful for treating, preventing, and eliminating side effects from various diseases and conditions as well as side effects from medication use. In some aspects, the consumable products are co-administered or co-formulated with other therapeutic agents.

Disclosed herein are consumable products for pets such as dogs, cats, horses, and birds the consumable products containing a cannabinoid. The consumable products disclosed herein can be formulated as chews or liquid supplements with pleasing flavors in order to encourage the pets to eat the consumable products and derive therapeutic benefits from consumption. The consumable products contain live, active cultures of probiotic microorganisms or may contain spores of probiotic microorganisms. The consumable products have anti-inflammatory effects due to the presence of the cannabinoid but are non-narcotic. Further, the consumable products serve to enhance gut health due to the presence of probiotics. The consumable products are particularly useful for treating, preventing, and eliminating side effects from various diseases and conditions as well as side effects from medication use. In some aspects, the consumable products are co-administered or co-formulated with other therapeutic agents.